1.Research advances in molecular targeted therapy for pancreatic cancer
Journal of Clinical Hepatology 2016;32(10):2026-2028
Pancreatic cancer remains one of the malignant tumors with the worst prognosis, and its incidence is associated with Western diet, smoking, drinking, obesity, chronic pancreatitis, and a family history of pancreatic cancer. Currently, the treatment of pancreatic cancer focuses on surgery and chemotherapy, but no ideal therapeutic effect has been achieved. An understanding of the specific molecular mechanism of the development of pancreatic cancer helps to better prevent and treat pancreatic cancer. This article introduces the latest advances in the specific molecular mechanism of the development of pancreatic cancer and its targeted therapy and points out that molecular-targeted therapy in addition to traditional treatment helps to improve the prognosis of patients with pancreatic cancer.
2.Research advances in portal hypertensive gastropathy
Guan HUANG ; Shulong DAI ; Kunxing YANG
Journal of Clinical Hepatology 2016;32(2):358-360
Portal hypertensive gastropathy (PHG) is a disease caused by cirrhotic (or non-cirrhotic) portal hypertension, with a typical feature of snake-skin appearance of the gastric mucosa under endoscope. Many studies have shown that portal hypertension is a necessary condition for the development and progression of PHG. PHG is often complicated by acute or chronic upper gastrointestinal bleeding, which may be the direct reason for patients to visit the hospital. Therefore, the study of the diagnosis and treatment of PHG is very important in clinical practice. This article reviews the research advances in the pathogenesis, classification, diagnosis, and treatment of PHG.
3.Biosynthesis of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli through introducing mevalonate pathway.
Tao WU ; Shengming WU ; Qing YIN ; Hongmei DAI ; Shulong LI ; Fangting DONG ; Bilian CHEN ; Hongqing FANG
Chinese Journal of Biotechnology 2011;27(7):1040-1048
Artemisinin-based combination therapies (ACTs) are recommended to be the most effective therapies for the first-line treatment of uncomplicated falciparum malaria. However, artemisinin is often in short supply and unaffordable to most malaria patients, which limits the wide use of ACTs. Production of amorpha-4,11-diene, an artemisinin precursor, was investigated by engineering a heterologous isoprenoid biosynthetic pathway in Escherichia coli. The production of amorpha-4,11-diene was achieved by expression of a synthetic amorpha-4,11-diene synthase gene in Escherichia coli DHGT7 and further improved by about 13.3 fold through introducing the mevalonate pathway from Enterococcus faecalis. After eliminating three pathway bottlenecks including amorpha-4,11-diene synthase, HMG-CoA reducase and mevalonate kinase by optimizing the metabolic flux, the yield of amorpha-4,11-diene was increased by nearly 7.2 fold and reached at 235 mg/L in shaking flask culture. In conclusion, an engineered Escherichia coli was constructed for high-level production of amorpha-4,11-diene.
Alkyl and Aryl Transferases
;
genetics
;
Antimalarials
;
metabolism
;
Artemisinins
;
metabolism
;
Enterococcus faecalis
;
genetics
;
Escherichia coli
;
genetics
;
metabolism
;
Metabolic Engineering
;
methods
;
Phosphotransferases (Alcohol Group Acceptor)
;
metabolism
;
Sesquiterpenes
;
metabolism
;
Transformation, Bacterial
4.Influence of tea pigment on cardiac activity in exsomatized toads of myocardial ischemia
Yu ZHANG ; Shufang DAI ; Zhidan WANG ; Yiping SUN ; Lei FU ; Kemin LIU ; Liang ZHU ; Shulong ZHANG
Chongqing Medicine 2018;47(5):588-589,593
Objective To observe the influence of tea pigment on myocardial contractility,electrocardiogram(ECG) and heart rate in exsomatized toads under the condition of myocardialischemia.Methods Sixty toads were divided into the normal exsomatized toad heart group(A) and myocardial ischemia toad heart(B).Then the group A was re-divided into the Ringer's solution group (A1),tea pigment low dose(200 mg/L) group(A2) and the high dose(400 mg/L) group(A3);the group B was re-divided into the pituitrin model group(B1),pituitrin + tea pigment low dose(200 mg/L) group(B2) and high dose(400 mg/L) group(B3).The BL-420S biological function experiment system was used to record the myocardial contractile force and ECG change curve of exsomatized toad.Results Compared with the group A1,the myocardial contractility in the group A3 was obviously increased(P<0.05),the difference in the group A2 had no statistical significance(P>0.05);the QRS peak value of ECG and heart rate had no statistically significant difference(P>0.05);compared with the group A1,the myocardial contractility,ECG QRS peak value and heart rate in the group B1 were significantly decreased(P<0.05);compared with the group B1,the myocardial contractility,ECG QRS peak value and heart rate in the group B2 and B3 were significantly increased(P<0.05).Conclusion Tea pigment can obviously improve the decrease of the exsomatized toad cardiac activity caused by myocardial ischemia.
5.Anti-HCV detection based on laboratory quality index evaluation of blood station
Yanli QIN ; Kangle WU ; Tian DAI ; Weiping FENG ; Shulong YANG
Chinese Journal of Blood Transfusion 2021;34(7):770-772
【Objective】 To evaluate the anti-HCV detection ability of our laboratory, and explore the factors that may affect anti-HCV detection, so as to provide data and basis for the evaluation of laboratory ability. 【Methods】 The number of initial reactive (IR) and repeated reactive(RR)samples and the reagent utilization rate in anti-HCV from 2019 to 2020 were compared with the national reagents of the same group. 【Results】 1)The average unqualified rate of anti-HCV detection was 0.25%, with the lowest rate at 0.19%, 33/17 774, and the highest rate at 0.37%, 44/11 940; 2)The retest rates of reagent 1 and reagent 2 were significantly different (P < 0.05); 3)The RR/IR rates of reagent 1 and reagent 2 showed no significant difference (P> 0.05), while the RR/IR rates of reagent 1 and reagent 2 showed a slow upward trend; 4)The solo reagent unqualified rate of reagent 1 and reagent 2 showed statistically significant difference (P < 0.05); 5)The reagent utilization rate was basically the same as the national average level of reagents in the same group. 【Conclusion】 The anti-HCV detection indicators of our laboratory are relatively stable, but other factors such as personnel training, equipment performance and environment also have an impact on the detection ability of laboratories. Fine management of various element should be carried out, and external quality assessment reports of blood testing laboratory should be analyzed to further improve the anti-HCV detection ability of the laboratory.